This is a snippet of the transcript, sign up to read more.
It's typical for large companies that use blends to work with antioxidant blenders rather than going directly to a BHA manufacturer. This is due to the flexibility, advice, support, and dosage they offer. Despite the large volumes these companies use, they are not that interesting for big chemical producers like BHA manufacturers. This is a historical trend.
This is a snippet of the transcript, sign up to read more.
Most of our business involved adjusting existing molecules and blends to make them workable for customers. For example, a blend that works perfectly in the Netherlands due to the mild weather may not be suitable for a Norwegian customer, where winter temperatures can drop to minus 15 degrees. This is where the expertise of antioxidant blenders comes in.
This is a snippet of the transcript, sign up to read more.
The differentiation then lies in the application basis. Manufacturers are advised on what to add and in what quantity based on their production process. This is done without revealing the entire process, thus protecting their business from competitors who might want to offer the same product. It's not just about blending; it's about the knowledge and application technology behind it.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research